Gaye Jordan

Gaye Jordan serves as an Acquisition Administrator at the Naval Health Research Center (N63116), where she plays a pivotal role in executing mission-critical procurements that support the health and operational readiness of Navy and Marine Corps personnel. She manages the full lifecycle of acquisitions for advanced biomedical technologies, including in-vitro diagnostic systems, analytical laboratory instruments, and wearable biosensor platforms. Her work directly enables the agency’s mission to detect, monitor, and mitigate health threats in operational environments through rapid diagnostic innovation and field-deployable medical solutions. Jordan ensures compliance with federal acquisition regulations while aligning procurement strategy with the Center’s scientific and operational priorities. While specific contractor names are not disclosed, Jordan maintains a robust network of vendors specializing in biomedical diagnostics, laboratory instrumentation, and health data analytics. Her procurement patterns reflect a preference for technically sophisticated suppliers capable of delivering validated, FDA-regulated, and ruggedized medical technologies suitable for austere environments. She engages with both large prime contractors and specialized small businesses, fostering partnerships that prioritize innovation, rapid prototyping, and regulatory compliance in high-stakes defense health applications. Jordan demonstrates a strong commitment to small business participation, with 27.5% of her acquisitions structured as set-asides—primarily through Total Small Business Set-Asides (FAR 19.5) and 8(a) competed contracts. Her socioeconomic strategy actively promotes competitive opportunities for small disadvantaged businesses while maintaining rigorous technical standards. This balanced approach ensures broad vendor engagement without compromising mission-critical performance requirements. Her primary procurement focus lies in NAICS 325413 (In-Vitro Diagnostic Substance Manufacturing), followed by analytical laboratory instrument manufacturing (334516) and specialized biomedical services (811219). She consistently acquires diagnostic reagents, point-of-care testing systems, and integrated biosensor platforms designed for infectious disease surveillance and physiological stress monitoring in deployed settings, reflecting deep technical expertise in defense medical innovation.